UTAH MEDICAL PRODUCTS, INC. AND SUBSIDIARIES CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Net income	$ 3,319	$ 2,994
Depreciation and amortization	1,121	299
Gain on investments	(6)	(24)
Provision for losses on accounts receivable	8	3
(Gain)/Loss on disposal of assets		0
Deferred income taxes	(174)
Stock-based compensation expense	49	44
Accounts receivable - trade	429	372
Accrued interest and other receivables	(40)	(20)
Inventories	(531)	140
Prepaid expenses and other current assets	43	18
Accounts payable	(174)	56
Accrued expenses	(26)
Deferred revenue	(21)
Other liability	449	(214)
Total adjustments	1,128	675
Net cash provided by operating activities	4,447	3,669
Capital expenditures for property and equipment	(158)	(762)
Capital expenditures for intangible assets	(7)
Purchases of investments	(500)	(1,200)
Proceeds from sale of investments	15,155	2,134
Net cash paid in acquisition	(41,084)
Net cash (used in) provided by investing activities	(26,594)	173
Proceeds from issuance of common stock - options	375	375
Common stock purchased and retired		(134)
Tax benefit attributable to exercise of stock options	23	26
Proceeds from note payable	26,934
Repayments of note payable	(1,927)	(180)
Payment of dividends	(851)	(853)
Net cash used in financing activities	24,555	(766)
Effect of exchange rate changes on cash	41	(53)
NET INCREASE IN CASH	2,449	3,022
CASH AT BEGINNING OF PERIOD	3,818	410
CASH AT END OF PERIOD	6,267	3,432
Cash paid during the period for income taxes	1,470	1,385
Cash paid during the period for interest	$ 354	$ 13